Pola-R-CHP or R-CHOEP for first-line therapy of younger patients with high-risk diffuse large B-cell lymphoma: a retrospective comparison of two randomized phase 3 trials
G. Lenz
(1)
,
H. Tilly
(2)
,
M. Ziepert
(3)
,
B. Altmann
(3)
,
C. Herbaux
(4)
,
F. Frontzek
(1)
,
M. Nickelsen
,
C. Lee
(5)
,
J. Hirata
(5)
,
D. Sahin
(6)
,
S. Chohan
(6)
,
C. L. Batlevi
(5)
,
M. Yan
(6)
,
N. Schmitz
(1)